Chinese Stocks’ Final-Hour Slide Shows Reliance on National Team

Chinese stocks extended losses in the final trading hour as investors, disappointed by the absence of national-team buying, sold shares. The Star 50 Index fell nearly 5%, while the CSI 300 declined 1.3%, contrasting with buoyant broader Asian trading amid renewed AI optimism following Anthropic PBC’s IPO filing.

Analysis

The key signal is not the size of the one-day decline, but the market’s apparent dependence on an expected official bid. If investors treat state buying as the marginal price setter, its absence can raise the equity risk premium and make rebounds less durable—especially in higher-beta growth shares. That can also widen the gap between large, policy-supported constituents and private-sector technology names, even if broad-index losses look contained.

Near term (days), positioning and expectations around official flows are likely to dominate fundamentals; avoid reading a single session as proof that support has been withdrawn. Over 1–3 months, the test is whether authorities deliver credible, sustained buying or policy measures that improve earnings expectations. Over 6–18 months, recurring dependence on intervention could discourage private capital formation and weigh on valuations and new issuance. The AI-led strength elsewhere is a relative-performance headwind for China growth unless domestic earnings or policy catalysts close the gap.

Contrarian check: one session cannot establish a regime change, and investors may be overreacting to the timing of support rather than its existence. We lack verified state-fund flow data, index-level positioning, and valuation context; do not assume the move is fundamentally justified. A durable stabilization in official flows and breadth would falsify the bearish relative-value view.

Key Decisions for Investors

• Consider a tactical, beta-controlled short in STAR 50 versus long CSI 300 exposure, sized as a relative-value position rather than an outright China short. Entry only if weakness persists alongside poor market breadth; cover if both indexes stabilize and growth leadership returns.
• Do not chase the initial selloff with broad China shorts. Verify official-fund flow data and subsequent-session breadth first; a visible, sustained bid would invalidate the intervention-withdrawal interpretation.
• For the next 1–3 months, keep China growth exposure below benchmark until policy support is evidenced by flows or earnings-relevant measures, not merely expected. Reassess on policy announcements, earnings guidance, and IPO funding conditions.
• Monitor the STAR 50/CSI 300 relative-performance spread and onshore turnover. A narrowing spread with improving breadth argues for closing the pair; continued underperformance without confirmed state buying supports maintaining it.